SEC Form 4 · accession 0001181431-15-004853
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lauren Bullaro Riker
Officer — Executive Director, Finance
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 16, 2015 | M | 5,000 | $10.34 | A | 7,230 | D | |
| Common Stock | Mar 16, 2015 | S | 5,000 | $95.34 | D | 2,230 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $10.34 | Mar 16, 2015 | M | 5,000 | D | — | May 10, 2021 | Common Stock | 5,000 | 25,000 | D |
Explanation of responses
- F1Includes 230 shares of common stock acquired under the issuer's employee stock purchase plan in December 2014.
- F2The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vests as to the remaining shares in successive equal monthly installments for the subsequent 36 months.